{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:09:35Z","timestamp":1784830175659,"version":"3.55.0"},"reference-count":14,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Rh\n                    <jats:sub>null<\/jats:sub>\n                    phenotype is the rarest of the Rh blood group system phenotypes and is characterized by the complete absence of all Rh antigens on red blood cells (RBCs). This phenotype carries major clinical relevance because of chronic hemolysis and profound transfusion incompatibility. We performed a scoping review to summarize the molecular basis, serologic features, clinical manifestations, and transfusion challenges associated with published Rh\n                    <jats:sub>null<\/jats:sub>\n                    cases. A systematic literature search of PubMed\/MEDLINE and Scopus was conducted from database inception to May 2025. Eligible reports included case reports, case series, or observational publications of individuals with the Rh\n                    <jats:sub>null<\/jats:sub>\n                    phenotype. Data were extracted and synthesized narratively according to a scoping review method. Six eligible publications describing eight individuals with the Rh\n                    <jats:sub>null<\/jats:sub>\n                    phenotype were identified. Common findings included chronic hemolytic anemia, stomatocy tosis or spherocytosis, and reticulocy tosis. Despite generally moderate intrinsic hematologic manifestations, the Rh\n                    <jats:sub>null<\/jats:sub>\n                    phenotype imposes a disproportionate transfusion burden because of near-complete donor scarcity. Anti-Rh29 alloimmunization was reported after transfusion or pregnancy exposure, restricting patients to Rh\n                    <jats:sub>null<\/jats:sub>\n                    RBC units from family members, frozen RBC inventories, or rare donor registries. Early recognition, molecular characterization, and proactive integration of eligible individuals with the Rh\n                    <jats:sub>null<\/jats:sub>\n                    phenotype into rare donor programs are critical for access to compatible blood.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2026-008","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:58:44Z","timestamp":1784825924000},"page":"42-47","source":"Crossref","is-referenced-by-count":0,"title":["Rh\n                    <sub>null<\/sub>\n                    phenotype: molecular basis, serologic features, clinical manifestations, and transfusion challenges\u2014a scoping review of\u00a0published cases"],"prefix":"10.2478","volume":"42","author":[{"given":"Ehsan","family":"Shahverdi","sequence":"first","affiliation":[{"name":"Department of Oncology, Hematology and Blood Stem Cell Transplantation , Klinikum Osnabr\u00fcck , Osnabr\u00fcck , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Moghaddam","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center , High Institute for Research and Education in Transfusion Medicine , Tehran , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026072317554378508_j_immunohematology-2026-008_ref_001","doi-asserted-by":"crossref","unstructured":"Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375\u201387.","DOI":"10.1182\/blood.V95.2.375"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_002","doi-asserted-by":"crossref","unstructured":"Daniels G. Human blood groups. 3rd ed. Oxford: Wiley-Blackwell, 2013.","DOI":"10.1002\/9781118493595"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_003","doi-asserted-by":"crossref","unstructured":"Flegel WA. Molecular genetics of RH and its clinical application. Transfus Clin Biol 2006;13:4\u201312.","DOI":"10.1016\/j.tracli.2006.02.011"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_004","doi-asserted-by":"crossref","unstructured":"Agre P, Cartron JP. Molecular biology of the Rh antigens. Blood 1991;78:551\u201363.","DOI":"10.1182\/blood.V78.3.551.551"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_005","doi-asserted-by":"crossref","unstructured":"Anstee DJ, Tanner MJ. Biochemical aspects of the blood group Rh (Rhesus) antigens. Baillieres Clin Haematol 1993;6: 401\u201322.","DOI":"10.1016\/S0950-3536(05)80152-0"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_006","doi-asserted-by":"crossref","unstructured":"Huang CH. Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol 1997;4:94\u2013103.","DOI":"10.1097\/00062752-199704020-00004"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_007","doi-asserted-by":"crossref","unstructured":"Cartron JP, Agre P. Rh blood groups and Rh deficiency syndrome. In: Cartron JP, Rouger P, Eds. Molecular basis of human blood group antigens. New York: Plenum Press 1995:189\u2013225.","DOI":"10.1007\/978-1-4757-9537-0_6"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_008","doi-asserted-by":"crossref","unstructured":"Vos GH, Vos D, Kirk RL, et al. A sample of blood with no detectable Rh antigens. Lancet 1961;277:14\u20135.","DOI":"10.1016\/S0140-6736(61)92183-3"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_009","unstructured":"Qureshi A, Salman M, Moiz B. Rhnull: a rare blood group phenotype. J Pak Med Assoc 2010;60:960\u20131."},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_010","doi-asserted-by":"crossref","unstructured":"Shahverdi E, Moghaddam M, Abolghasemi H. First report of known rare Rhnull phenotype individuals in Iran. Int J Hematol Oncol Stem Cell Res 2018;12:180\u20133.","DOI":"10.18502\/ijhoscr.v13i1.317"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_011","doi-asserted-by":"crossref","unstructured":"Shahverdi E, Baschin M, Moghaddam M. An update on known rare Rhnull phenotype individuals in Iran. Int J Hematol Oncol Stem Cell Res 2019;13:1\u20135.","DOI":"10.18502\/ijhoscr.v13i1.317"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_012","doi-asserted-by":"crossref","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169:467\u201373.","DOI":"10.7326\/M18-0850"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_013","doi-asserted-by":"crossref","unstructured":"Anstee DJ. The relationship between blood groups and disease. Blood 2010;115:4635\u201343.","DOI":"10.1182\/blood-2010-01-261859"},{"key":"2026072317554378508_j_immunohematology-2026-008_ref_014","doi-asserted-by":"crossref","unstructured":"Peyrard T, Pham BN, Le Pennec PY, Rouger P. The rare blood groups: a public health challenge. Transfus Clin Biol 2008;15:109\u201319.","DOI":"10.1016\/j.tracli.2008.02.001"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2026-008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:55:51Z","timestamp":1784829351000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2026-008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/immunohematology-2026-008"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2026-008","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}